F. Bruniquel

Biochemical Changes and Morphological Alterations of Liver and Kidney in Hamsters after Administration of the HMG‐Coenzyme A Reductase Inhibitor, Simvastatin: Prevention and Reversibility by Mevalonate *

P. Oms, N. Assie, F. Bruniquel, 1995 .

Anti-Atherosclerotic Properties of the Acyl-coenzyme A:Cholesterol Acyltransferase Inhibitor F 12511 in Casein-Fed New Zealand Rabbits

P. Fauré, D. Junquéro, F. Bruniquel, 2002, Journal of cardiovascular pharmacology.

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.

F. Colpaert, D. Junquéro, F. Bruniquel, 2001, Atherosclerosis.

Pharmacological modulation of PAF-acether-induced pleurisy in rats.

J. Couzinier, F. Bruniquel, A. Delhon, 1987, Pharmacological research communications.

Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.

J. Couzinier, F. Bruniquel, A. Delhon, 1986, European journal of pharmacology.

Pharmacological studies on zymosan inflammation in rats and mice. 1: Zymosan-induced paw oedema in rats and mice.

N. Consul, F. Bruniquel, A. Delhon, 1989, Pharmacological research.

Pharmacological studies on zymosan inflammation in rats and mice. 2: Zymosan-induced pleurisy in rats.

N. Consul, F. Bruniquel, A. Delhon, 1989, Pharmacological research.

Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.

P. Oms, N. Assie, F. Bruniquel, 1994, Pharmacology & toxicology.